NeOnc executives buy $629K of stock after Phase 2a results
NeOnc said senior executives purchased about $629,000 of shares after positive NEO100 Phase 2a results, including CEO purchases totaling 111,000 shares.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.